1. Home
  2. MYGN vs VECO Comparison

MYGN vs VECO Comparison

Compare MYGN & VECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYGN
  • VECO
  • Stock Information
  • Founded
  • MYGN 1991
  • VECO 1945
  • Country
  • MYGN United States
  • VECO United States
  • Employees
  • MYGN N/A
  • VECO N/A
  • Industry
  • MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • VECO Industrial Machinery/Components
  • Sector
  • MYGN Health Care
  • VECO Technology
  • Exchange
  • MYGN Nasdaq
  • VECO Nasdaq
  • Market Cap
  • MYGN 2.0B
  • VECO 1.9B
  • IPO Year
  • MYGN 1995
  • VECO 1994
  • Fundamental
  • Price
  • MYGN $17.41
  • VECO $28.68
  • Analyst Decision
  • MYGN Buy
  • VECO Buy
  • Analyst Count
  • MYGN 12
  • VECO 7
  • Target Price
  • MYGN $28.18
  • VECO $42.14
  • AVG Volume (30 Days)
  • MYGN 874.8K
  • VECO 626.4K
  • Earning Date
  • MYGN 11-07-2024
  • VECO 11-06-2024
  • Dividend Yield
  • MYGN N/A
  • VECO N/A
  • EPS Growth
  • MYGN N/A
  • VECO N/A
  • EPS
  • MYGN N/A
  • VECO 1.35
  • Revenue
  • MYGN $823,600,000.00
  • VECO $709,094,000.00
  • Revenue This Year
  • MYGN $13.95
  • VECO $9.24
  • Revenue Next Year
  • MYGN $9.71
  • VECO $9.96
  • P/E Ratio
  • MYGN N/A
  • VECO $21.17
  • Revenue Growth
  • MYGN 12.15
  • VECO 9.71
  • 52 Week Low
  • MYGN $16.00
  • VECO $26.71
  • 52 Week High
  • MYGN $29.30
  • VECO $49.25
  • Technical
  • Relative Strength Index (RSI)
  • MYGN 21.54
  • VECO 37.87
  • Support Level
  • MYGN $16.86
  • VECO $28.41
  • Resistance Level
  • MYGN $18.57
  • VECO $31.00
  • Average True Range (ATR)
  • MYGN 1.12
  • VECO 0.88
  • MACD
  • MYGN -0.37
  • VECO 0.04
  • Stochastic Oscillator
  • MYGN 8.94
  • VECO 10.42

About MYGN Myriad Genetics Inc.

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.

About VECO Veeco Instruments Inc.

Veeco Instruments Inc is a United States-based company that is principally engaged in designing, developing, and manufacturing thin-film process equipment, which is mainly used to produce electronic devices. The company's product categories by market consist of lighting, display, and power electronics; advanced packaging; MEMS and RF; scientific and industrial; and data storage. The lighting, display, and power electronics market accounts for over half of the total revenue. The company offers products and services in the United States; China; Europe, the Middle East, and Africa, or EMEA; and the rest of the world, with overseas markets contributing the majority of total revenue.

Share on Social Networks: